Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$0.28 - $1.16 $14.9 Million - $61.9 Million
-53,323,046 Reduced 95.45%
2,542,002 $838,000
Q1 2024

Apr 19, 2024

SELL
$1.06 - $1.67 $2.52 Million - $3.96 Million
-2,373,867 Reduced 4.08%
55,865,048 $64.8 Million
Q4 2023

Jan 30, 2024

SELL
$1.26 - $1.79 $639,128 - $907,968
-507,245 Reduced 0.86%
58,238,915 $98.4 Million
Q3 2023

Oct 30, 2023

BUY
$1.61 - $2.54 $12.8 Million - $20.2 Million
7,958,613 Added 15.67%
58,746,160 $106 Million
Q2 2023

Jul 31, 2023

BUY
$1.14 - $1.95 $9.34 Million - $16 Million
8,190,952 Added 19.23%
50,787,547 $94.5 Million
Q1 2023

Apr 27, 2023

BUY
$1.2 - $2.19 $6.1 Million - $11.1 Million
5,082,277 Added 13.55%
42,596,595 $56.7 Million
Q4 2022

Jan 30, 2023

BUY
$1.63 - $3.52 $10.6 Million - $23 Million
6,532,370 Added 21.08%
37,514,318 $63.4 Million
Q3 2022

Oct 21, 2022

BUY
$0.73 - $3.74 $6.66 Million - $34.1 Million
9,123,775 Added 41.74%
30,981,948 $96.7 Million
Q2 2022

Jul 26, 2022

BUY
$2.2 - $4.2 $48.1 Million - $91.8 Million
21,858,173 New
21,858,173 $52 Million
Q1 2022

Apr 27, 2022

SELL
$2.83 - $8.69 $32 Million - $98.3 Million
-11,307,008 Closed
0 $0
Q4 2021

Feb 02, 2022

BUY
$8.31 - $14.92 $56.1 Million - $101 Million
6,754,325 Added 148.36%
11,307,008 $94 Million
Q3 2021

Oct 25, 2021

BUY
$9.15 - $13.28 $41.7 Million - $60.5 Million
4,552,683 New
4,552,683 $52.8 Million

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Sumitomo Mitsui Trust Holdings, Inc. Portfolio

Follow Sumitomo Mitsui Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.